TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35189544

Group type: EXPERIMENTAL
Intervention: Lumbar drain (LD) insertion at the time of surgery
Number of subjects: 38

Group type: COMPARATOR
Intervention: No lumbar drain (no LD) placement
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Lumbar drain (LD) insertion
Number of subjects: 38
Study: 34492522

Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg once daily
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 36018418

Group type: EXPERIMENTAL
Intervention: Modified vacuum‐formed retainers (mVFRs)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Hawley retainers (HRs)
Number of subjects: 35
Study: 36421044

Group type: EXPERIMENTAL
Intervention: A-PRF
Number of subjects: 17

Group type: COMPARATOR
Intervention: SCTG
Number of subjects: 17
Study: 34109594

Group type: EXPERIMENTAL
Intervention: Probiotic Sanprobi Barrier (2.5 × 10^9 CFU)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 32857481

Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogen (oCEE)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Transdermal 17β‐estradiol (tE2)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 35251499

Group type: EXPERIMENTAL
Intervention: Two 4.5 mm cannulated screws (CCS group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Kirschner wire (K wire group)
Number of subjects: 60
Study: 33213529

Group type: EXPERIMENTAL
Intervention: Zilucoplan (32.4 mg subcutaneously daily) plus IV ceftriaxone (2g daily for 14 days) and standard of care
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard of care plus IV ceftriaxone (2g daily for 1 week)
Number of subjects: 81
Study: 34233983

Group type: EXPERIMENTAL
Intervention: CCENT model (coached, coordinated, enhanced neonatal transition)
Number of subjects: 236
Study: 32404287

Group type: EXPERIMENTAL
Intervention: Aerobic treadmill training for 12 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 22
Study: 35829971

Group type: EXPERIMENTAL
Intervention: MyChoices app
Number of subjects: 60
Study: 34511184

Group type: EXPERIMENTAL
Intervention: Vadadustat 150 mg with sodium ferrous citrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vadadustat 150 mg with ferric citrate hydrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vadadustat 150 mg with sucroferric oxyhydroxide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vadadustat 150 mg with ferrous sulfate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vadadustat 150 mg without iron-containing agents
Number of subjects: 0
Study: 35034664

Group type: EXPERIMENTAL
Intervention: EMG-driven robot-assisted therapy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Task-oriented training
Number of subjects: 24
Study: 34125699

Group type: EXPERIMENTAL
Intervention: PBO-LLINs
Number of subjects: 1010

Group type: COMPARATOR
Intervention: Standard LLINs
Number of subjects: 1010
Study: 36231735

Group type: EXPERIMENTAL
Intervention: Family Strengthening Intervention for Refugees (FSI-R)
Number of subjects: 80
Study: 33882893

Group type: EXPERIMENTAL
Intervention: Telemonitoring of adherence to inhalation therapies, weekly home spirometry, video-conferencing, self-management app, professional telephone coaching.
Number of subjects: 402

Group type: COMPARATOR
Intervention: Standard-of-care arm (control group).
Number of subjects: 402
Study: 32567356

Group type: EXPERIMENTAL
Intervention: Biopsychosocial intervention delivered in six structured two-hour sessions
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 41
Study: 33863342

Group type: EXPERIMENTAL
Intervention: Individualised supported self‐management approach for physical activity (LEAP-MS)
Number of subjects: 0
Study: 35912671

Group type: EXPERIMENTAL
Intervention: Increased availability of lower energy options (70%)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard availability of lower energy options (30%)
Number of subjects: 77
Study: 33025024

Group type: EXPERIMENTAL
Intervention: Diesel exhaust exposure
Number of subjects: 38375

Group type: EXPERIMENTAL
Intervention: Polycyclic aromatic hydrocarbons (PAH) exposure
Number of subjects: 38375

Group type: COMPARATOR
Intervention: Control group (breast cancer-free women)
Number of subjects: 38375
Study: 32255266

Group type: COMPARATOR
Intervention: Corticosteroid (triamcinolone acetonide, 60 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Leucocyte-rich platelet-rich plasma (LR-PRP)
Number of subjects: 50
Study: 32281430

Group type: EXPERIMENTAL
Intervention: One stacked pulsed dye laser (PDL) technique
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Stacked pulsed dye laser (PDL) in two sessions, 1 month apart
Number of subjects: 22
Study: 36202557

Group type: EXPERIMENTAL
Intervention: MitraClip implantation plus guideline‐directed medical therapy (GDMT)
Number of subjects: 614

Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 614
Study: 33386332

Group type: EXPERIMENTAL
Intervention: 2-dose regimen (0, 6)
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: 2-dose regimen (0, 12)
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: 3-dose regimen (0, 2, 6)
Number of subjects: 1207
Study: 34201450

Group type: EXPERIMENTAL
Intervention: Standard Group and Enhanced Group received 20 smoking-related messages over 2 weeks; Enhanced Group received an extra 6 oral health-related messages for one week.
Number of subjects: 403

Group type: COMPARATOR
Intervention: WeChat-based smoking cessation intervention
Number of subjects: 403
Study: 33859297

Group type: COMPARATOR
Intervention: Transcranial static magnetic stimulation (tSMS) over the left primary motor cortex for 20 min
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study: 32807102

Group type: EXPERIMENTAL
Intervention: Blinded safety data analysis
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Unblinded safety data analysis
Number of subjects: 53
Study: 36414975

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 250 mg infusion (1 × 250 mg over 5 min)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (4 mL isotonic saline NaCl 0.9%)
Number of subjects: 120
Study: 33293396

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4000 IU per day)
Number of subjects: 860

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 860
Study: 35913755

Group type: EXPERIMENTAL
Intervention: General exercise intervention (≥2.5 hours of intense physical activity/week)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (continued exercise as usual)
Number of subjects: 151
Study: 33774890

Group type: EXPERIMENTAL
Intervention: Male suffering PWL
Number of subjects: 785

Group type: COMPARATOR
Intervention: Health information PWL
Number of subjects: 785
Study: 32350555

Group type: EXPERIMENTAL
Intervention: Participation in interdisciplinary tumor boards at university hospitals
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Participation in interdisciplinary tumor boards at level 3 hospitals
Number of subjects: 54
Study: 33016374

Group type: EXPERIMENTAL
Intervention: Rivastigmine (placebo-adjusted effect on ADAS-Cog at week 24)
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Rivastigmine (capsules)
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Rivastigmine (patch)
Number of subjects: 1047

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 1047
Study: 35051316

Group type: EXPERIMENTAL
Intervention: Conventional dentifrice (Colgate Maximum Anticaries Protection)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Dentifrice containing 2% hydrogen peroxide (Colgate Luminous White Advanced)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Dentifrice containing sodium tripolyphosphate (Sensodyne True White)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Dentifrice containing activated charcoal (Black is White)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Dentifrice containing blue covarine (Close Up White Now)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (brushing with only water)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: All whitening dentifrices
Number of subjects: 105
Study: 35717820

Group type: EXPERIMENTAL
Intervention: ICI-based therapy (monotherapy or combination)
Number of subjects: 1145

Group type: COMPARATOR
Intervention: VEGF inhibitor monotherapy
Number of subjects: 1145

Group type: COMPARATOR
Intervention: mTOR inhibitor monotherapy
Number of subjects: 1145
Study: 33632904

Group type: EXPERIMENTAL
Intervention: Low-flow anesthesia
Number of subjects: 44

Group type: COMPARATOR
Intervention: High-flow anesthesia
Number of subjects: 44
Study: 34232300

Group type: EXPERIMENTAL
Intervention: Family Connects (FC) program with 1 to 3 nurse home visits starting at 3 weeks of age.
Number of subjects: 549

Group type: COMPARATOR
Intervention: Control group (treatment as usual).
Number of subjects: 549
Study: 33883772

Group type: EXPERIMENTAL
Intervention: Living environment factors (safe drinking water, sanitation, hygiene, etc.)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Family characteristics (parental education, occupation, income)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Availability of safe drinking water and sanitation, use of mosquito nets
Number of subjects: 224
Study: 34738161

Group type: EXPERIMENTAL
Intervention: Bolus group (0.5 mg penehyclidine injected before anesthesia)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Infusion group (0.25 mg penehyclidine injected before anesthesia and another 0.25 mg infused after surgery)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Control group (placebo normal saline injected before anesthesia and infused over 48 hours after surgery)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Bolus group
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Infusion group
Number of subjects: 354
Study: 33086290

Group type: COMPARATOR
Intervention: Pred+NSAID-Pre (control group)
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Pred+NSAID-Post
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: NSAID-Pre
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: NSAID-Post
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Dropless group (sub-Tenon depot of dexamethasone)
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Pred+NSAID-Pre and Pred+NSAID-Post groups
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: NSAID monotherapy and dropless groups
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 456
Study: 32269028

Group type: EXPERIMENTAL
Intervention: 1-week free nicotine replacement therapy (NRT) sample (either patch or gum) plus brief medication advice and cessation service referral.
Number of subjects: 825

Group type: COMPARATOR
Intervention: Brief smoking cessation advice and service referral (control group).
Number of subjects: 825
Study: 35201290

Group type: EXPERIMENTAL
Intervention: Esophageal-sparing intensity-modulated RT (ES-IMRT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard RT (control arm)
Number of subjects: 90
Study: 32811681

Group type: EXPERIMENTAL
Intervention: Sequential radiation followed by chemotherapy (RT‐CT)
Number of subjects: 17070

Group type: COMPARATOR
Intervention: Concurrent chemoradiation (CCRT)
Number of subjects: 17070

Group type: COMPARATOR
Intervention: Sequential chemotherapy followed by radiation (CT‐RT)
Number of subjects: 17070
Study: 34499248

Group type: EXPERIMENTAL
Intervention: Contact Lens Dynamometry (CLD)
Number of subjects: 36

Group type: COMPARATOR
Intervention: IOPstim
Number of subjects: 36
Study: 33789270

Group type: EXPERIMENTAL
Intervention: Cochlear Implantation (CI)
Number of subjects: 155

Group type: COMPARATOR
Intervention: CROS hearing aids
Number of subjects: 155

Group type: COMPARATOR
Intervention: Bone-Anchored Hearing Systems (BAHS)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 155
Study: 35077956

Group type: EXPERIMENTAL
Intervention: Abstinence-contingent wage supplements
Number of subjects: 91

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 91
Study: 33719913

Group type: EXPERIMENTAL
Intervention: Positive text flyer
Number of subjects: 1070

Group type: EXPERIMENTAL
Intervention: Positive graphics flyer
Number of subjects: 1070

Group type: COMPARATOR
Intervention: Neutral text flyer
Number of subjects: 1070
Study: 32654156

Group type: EXPERIMENTAL
Intervention: Inotersen, weekly subcutaneous administration for 65 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo, weekly subcutaneous administration for 65 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inotersen
Number of subjects: 0
Study: 35142000

Group type: EXPERIMENTAL
Intervention: Complex Oral Semantic Fluency (COSEF) task
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Phonemic and two types of semantic COWATs
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: COSEF task
Number of subjects: 17

Group type: COMPARATOR
Intervention: COWATs
Number of subjects: 17
Study: 34305642

Group type: EXPERIMENTAL
Intervention: Nocturnal Oxygen Therapy (NOT) at 3 L/min
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (ambient air 3 L/min)
Number of subjects: 23
Study: 35621054

Group type: EXPERIMENTAL
Intervention: Passiflora setacea juice (50 g, 150 g)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Passiflora setacea juice (50 g)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Phenolic metabolites from Passiflora setacea
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PB)
Number of subjects: 24
Study: 32193264

Group type: EXPERIMENTAL
Intervention: 6 months RET and 800 IU/d vitamin D3
Number of subjects: 127

Group type: COMPARATOR
Intervention: 6 months RET and placebo
Number of subjects: 127
Study: 35649057

Group type: EXPERIMENTAL
Intervention: Telemedicine Group (n=48)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Face-to-Face Group
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Telemedicine Group
Number of subjects: 98
Study: 34395624

Group type: EXPERIMENTAL
Intervention: 1 μg/kg dose of nitroglycerin
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 2 μg/kg dose of nitroglycerin
Number of subjects: 78

Group type: COMPARATOR
Intervention: Normal saline or placebo (control group)
Number of subjects: 78
Study: 32925119

Group type: EXPERIMENTAL
Intervention: Sensor-based motor rehabilitation (experimental group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional neurorehabilitation (control group)
Number of subjects: 30
Study: 35370050

Group type: EXPERIMENTAL
Intervention: Nonabsorbable sutures
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Absorbable sutures
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Metallic staples
Number of subjects: 124

Group type: COMPARATOR
Intervention: All groups (nonabsorbable sutures, absorbable sutures, metallic staples)
Number of subjects: 124
Study: 33662334

Group type: EXPERIMENTAL
Intervention: Combination of anti-IL-21 and liraglutide
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Anti-IL-21 alone
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Liraglutide alone
Number of subjects: 308

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: All active treatments (anti-IL-21 + liraglutide, anti-IL-21, liraglutide)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 308
Study: 35238894

Group type: EXPERIMENTAL
Intervention: Pemafibrate 0.2 mg twice a day
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Pemafibrate (all doses)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Pemafibrate
Number of subjects: 408

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 408
Study: 33069624

Group type: EXPERIMENTAL
Intervention: Microultrasound (microUS) using the ExactVu system before prostate biopsy
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Combination of microUS-targeted and randomized biopsies
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: PRI‐MUS score
Number of subjects: 320
Study: 33109926

Group type: EXPERIMENTAL
Intervention: Placebo groups (informed that the application of an inert cream would reduce pain)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Nocebo groups (informed that the application of an inert cream would amplify pain)
Number of subjects: 166

Group type: COMPARATOR
Intervention: No-expectancy control group
Number of subjects: 166
Study: 32503395

Group type: EXPERIMENTAL
Intervention: Doctor Office Collaboration Care (DOCC)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Medication use
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Medication continuity
Number of subjects: 206

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 206
Study: 36446950

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading dose)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Aspirin (loading and maintenance doses)
Number of subjects: 169
Study: 32251173

Group type: EXPERIMENTAL
Intervention: Immersive virtual reality curriculum for clinical assessment training
Number of subjects: 0
Study: 34792133

Group type: EXPERIMENTAL
Intervention: Letrozole (5 mg/day)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 33336450

Group type: EXPERIMENTAL
Intervention: Music group
Number of subjects: 107

Group type: COMPARATOR
Intervention: Non-music group
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 107
Study: 32730052

Group type: EXPERIMENTAL
Intervention: Implementation intentions statement only
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Implementation intentions statement combined with visualization
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Imagine in Game
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Imagine in Daily Life
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Statement and Imagine Combined
Number of subjects: 250
Study: 34787718

Group type: EXPERIMENTAL
Intervention: Gingival unit graft (GUG)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Connective tissue graft (SCTG)
Number of subjects: 16
Study: 34117965

Group type: EXPERIMENTAL
Intervention: mHealth facilitated health coaching intervention (Fitbit Plus)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Substance use
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 53
Study: 35315592

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich diet (PR diet)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 51
Study: 35176208

Group type: EXPERIMENTAL
Intervention: Drugs with anticholinergic properties (DAPs) prescribed to patients
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: High KABS (≥ 3)
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Specific DAPs contributing to total KABS
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Factors associated with high KABS
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Quality of life in patients with high DAP burden
Number of subjects: 466
Study: 33714401

Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35308520

Group type: EXPERIMENTAL
Intervention: THRIVE
Number of subjects: 100
Study: 34139998

Group type: EXPERIMENTAL
Intervention: Dialysate sodium concentration of 137 meq/l
Number of subjects: 41

Group type: COMPARATOR
Intervention: Dialysate sodium concentration of 140 meq/l
Number of subjects: 41
Study: 32817713

Group type: EXPERIMENTAL
Intervention: Monocular spherical blur
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Binocular spherical blur
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Binocular astigmatic blur
Number of subjects: 39

Group type: COMPARATOR
Intervention: Habitual near vision
Number of subjects: 39
Study: 35697127

Group type: EXPERIMENTAL
Intervention: Cap-assisted EMR (EMR-C)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Standard inject and cut EMR (EMR-S)
Number of subjects: 240
Study: 34836211

Group type: COMPARATOR
Intervention: TRX suspension training + placebo (TP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: TRX suspension training + taurine supplementation (TT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Taurine supplementation (T)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 40
Study: 35565768

Group type: EXPERIMENTAL
Intervention: Chronic sleep restriction (CSR, 1:3.3 sleep:wake ratio, n = 9)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (1:2 sleep:wake ratio, n = 8)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both groups (Control and CSR)
Number of subjects: 17
Study: 34154624

Group type: EXPERIMENTAL
Intervention: Combined model using radiomics features and clinical factors
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Combined model
Number of subjects: 224

Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 224

Group type: COMPARATOR
Intervention: Combined model vs Clinical model
Number of subjects: 224
Study: 32017777

Group type: EXPERIMENTAL
Intervention: Remote limb ischemic conditioning (RLIC) plus strength training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham conditioning plus strength training
Number of subjects: 30
Study: 34937416

Group type: EXPERIMENTAL
Intervention: Modified Cogmed Training (MCT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment as Usual (CON)
Number of subjects: 40
Study: 32357132

Group type: EXPERIMENTAL
Intervention: Intravascular ultrasound (IVUS) use during atherectomy procedures
Number of subjects: 114462

Group type: EXPERIMENTAL
Intervention: Orbital atherectomy
Number of subjects: 114462

Group type: COMPARATOR
Intervention: Non-orbital atherectomy
Number of subjects: 114462
Study: 616389141

Group type: EXPERIMENTAL
Intervention: 1 x 3 soft capsules of BCSO (0.5 ml each)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 2 x 3 soft capsules of BCSO (0.5 ml each)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 3 x 3 soft capsules of BCSO (0.5 ml each)
Number of subjects: 36
Study: 35639451

Group type: EXPERIMENTAL
Intervention: Four online simulation modules (15-20 min each)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (n=49)
Number of subjects: 102